In the BioHarmony Drug Report Database

"Preview" Icon

Hexaminolevulinate

Cysview (hexaminolevulinate) is a small molecule pharmaceutical. Hexaminolevulinate was first approved as Cysview on 2010-05-28. Cysview’s patent is valid until 2036-12-19 (FDA).

 

Trade Name

 

Cysview
 

Common Name

 

hexaminolevulinate
 

ChEMBL ID

 

CHEMBL1201784
 

Indication

 

 

Drug Class

 

Image (chem structure or protein)

Hexaminolevulinate structure rendering